Characterization of the nutrient assimilation pathways in M. tuberculosis
Characterization of the nutrient assimilation pathways in M. tuberculosis
批准号:
10507765
负责人:
Brian C VanderVen
金额:
$59.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-11-19 至 2025-10-31
关键词:
ATP phosphohydrolaseAnti-Inflammatory AgentsArachidonic AcidsBacteriaBiochemicalBiochemical PathwayCarbonCessation of lifeCharacteristicsChemicalsCholesterolChronicComplexDataDedicationsDegradation PathwayDinoprostoneDiseaseDrug TargetingEicosanoidsEnzymesFatty AcidsFundingGenesGeneticGranulomaHumanImmuneImmune responseImmune signalingInfectionKnowledgeLipidsLungMacrophageMediatingMetabolicMetabolic PathwayModelingMusMycobacterium tuberculosisNutrientOperonPathogenesisPathway interactionsPharmaceutical PreparationsPhenotypePlayPositioning AttributeProcessProtein SubunitsProteinsResearchRoleSourceStarvationSubstrate SpecificitySystemTherapeuticTimeTuberculosisVirulenceVirulence FactorsWorkbacterial fitnesschronic infectiondrug developmentfatty acid transportgenetic approachimmunoregulationin vivomouse modelmutantnovelnutritionpathogenpathogenic bacteriapolyketides
中文摘要
项目摘要/摘要
结核分枝杆菌利用宿主衍生的脂质促进发病,这是这种细胞内的一个决定性特征
病原体。在感染期间,结核分枝杆菌输入和代谢宿主脂类,通过产生:i)
能量,ii)中枢代谢中间体,或iii)多酮毒性脂质。而结核分枝杆菌的代谢途径
降解或加工脂质是复杂的,包含多余的酶,细菌MCE脂质转运蛋白
似乎是专用脂质底物所特有的。
这项工作的目标1建议使用遗传和生化方法来识别和表征新的
结核分枝杆菌中脂肪酸进口所需的基因/蛋白质。虽然据了解,Mce1进口脂肪酸,但
这种转运蛋白的底物专一性尚不清楚。因此,我们打算定义底物和生化
根据Mce1底物的特异性。我们的初步研究表明,Mtb运输脂肪酸前体
通过Mce1的免疫信号脂质,我们在这里包括评估是否清除这种免疫脂质的研究
结核分枝杆菌的前体影响免疫反应。
目标2建议确定和表征由所有MCE转运体和
在结核分枝杆菌中脂肪进口是必需的。我们已经确定Mce1和Mce4介导的LUCA是必需的
运输和卢卡稳定这些运输复合体。这些研究试图描述这一点的基础。
传送器稳定了。同样,Mce1和Mce4介导的运输需要MceG,我们打算
了解MceG如何稳定Mce1并与Mce1相互作用。我们将用基因的方法让卢卡和
检测慢性感染小鼠体内结核分枝杆菌的MceG,并量化细菌适合性以确定治疗潜力
有可能阻断这些蛋白质的药物。
英文摘要
Project Summary / Abstract
Mtb utilizes host-derived lipids to promote pathogenesis and this is a defining feature of this intracellular
pathogen. During infection Mtb imports and metabolizes host lipids to support pathogenesis by producing: i)
energy, ii) central metabolic intermediates, or iii) polyketide virulence lipids. While the metabolic pathways in Mtb
that degrade or process lipids are complex and contain redundant enzymes, the bacterial Mce lipid transporters
appear to be specific for dedicated lipid substrates.
Aim 1 of this work proposes to employ genetic and biochemical approaches to identify and characterize novel
gene/proteins required for fatty acid import in Mtb. While it is understood that Mce1 imports fatty acids, the
substrate specificity of this transporter is unknown. Therefore, we intend to define substrates and the biochemical
basis of Mce1 substrate specificity. Our preliminary studies indicate that Mtb transports fatty acid precursors of
immune signaling lipids via Mce1 and we include here studies to evaluate if scavenging of this immune lipid
precursors by Mtb impacts the immune response.
Aim 2 proposes to identify and characterize protein subunits that are shared by all the Mce transporters and
are required for lipid import in Mtb. We have determined that LucA is required for Mce1- and Mce4-mediated
transport and LucA stabilizes these transporter complexes. These studies seek to characterize the basis for this
transporter stabilization. Similarly, MceG is required for Mce1- and Mce4-mediated transport and we intend to
understand how MceG stabilizes and interacts with Mce1. We will use a genetic approach to silence LucA and
MceG in Mtb within chronically infected mice and quantify bacterial fitness to determine the therapeutic potential
of drugs that potentially block these proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of the nutrient assimilation pathways in M. tuberculosis
-
批准号:10304930
-
项目类别:
-
资助金额:$64.02万
-
财政年份:2020
-
负责人:Brian C VanderVen
-
依托单位:
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.
-
批准号:9448277
-
项目类别:
-
资助金额:$45.43万
-
财政年份:2017
-
负责人:Brian C VanderVen
-
依托单位:
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.
-
批准号:9759755
-
项目类别:
-
资助金额:$45.66万
-
财政年份:2017
-
负责人:Brian C VanderVen
-
依托单位:
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.
-
批准号:9571196
-
项目类别:
-
资助金额:$46.13万
-
财政年份:2017
-
负责人:Brian C VanderVen
-
依托单位:
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.
-
批准号:10237310
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2017
-
负责人:Brian C VanderVen
-
依托单位:
Exploiting metabolic toxicities to identify compounds that inhibit cholesterol metabolism in M. Tuberculosis
-
批准号:9241338
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:Brian C VanderVen
-
依托单位:
Exploiting metabolic toxicities to identify compounds that inhibit cholesterol metabolism in M. Tuberculosis
-
批准号:8940939
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:Brian C VanderVen
-
依托单位:
Analysis of host-derived nutrient utilization pathways in M. tuberculosis
-
批准号:8442522
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2013
-
负责人:Brian C VanderVen
-
依托单位:
Analysis of host-derived nutrient utilization pathways in M. tuberculosis
-
批准号:8613432
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2013
-
负责人:Brian C VanderVen
-
依托单位:
海外基金